Numerous scientific studies point to the crucial role played by inflammatory processes in the development of psychiatric disorders. Of particular significance here is, amongst other things, the interleukin 6/STAT3 signalling pathway, which is associated with depression, schizophrenia and bipolar disorder.
Researchers at MedUni Vienna, led by Daniela Pollak at the Centre for Physiology and Pharmacology, have now demonstrated that STAT3 plays a significant role in the serotonergic system as a molecular mediator for the regulation of emotional reactivity. They were thus able to demonstrate that there is a link between the immune system, the transmission of information from one nerve cell to another via serotonin, and affective disorders such as depression.
In the study, which has now been published, the importance of the STAT3 signal transduction pathway was specifically investigated in the serotonergic system of the midbrain – a centre for the regulation of emotions – by selectively inhibiting STAT3 in a mouse model. Pollak: “When STAT3 was selectively absent from the serotonergic system of the midbrain, the mice exhibited reduced negative emotional reactivity in their behaviour, as well as a diminished response to the effects of amphetamine in the brain. Furthermore, changes in molecular networks relevant to neuropsychiatric disorders were also observed at the level of gene expression.
References:
Medical University of Vienna
https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-in-october-2020/stat3-identified-as-a-key-factor-in-emotional-reactivity/
STAT3 in the raphe nuclei gates behavioural reactivity and regulates gene networks associated with neuropsychiatric disorders, Molecular Psychiatry, https://www.nature.com/articles/s41380-020-00904-2